Ocular Manifestations of Paediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Giorgio Ottaviano1, Silvia Salvatore1, Alessandro Salvatoni1

  • 1Pediatric Department, Ospedale 'F. Del Ponte', Università dell'Insubria, Varese, Italy.

Insights

Ocular manifestations in pediatric inflammatory bowel disease are uncommon but may be underestimated. Children with Crohn's disease have a higher risk of these eye complications.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Gastroenterology

Background:

  • Ocular extraintestinal manifestations (O-EIMs) are known complications of pediatric inflammatory bowel disease (IBD), including Crohn's disease (CD), ulcerative colitis (UC), and IBD unclassified (IBD-U).
  • Limited data exist on the prevalence of O-EIMs in children, and there are no clear follow-up recommendations.
  • This study addresses the scarcity of information regarding O-EIMs in pediatric IBD populations.

Purpose of the Study:

  • To review available data on the prevalence of O-EIMs in children with IBD.
  • To assess the risk of O-EIMs in different types of pediatric IBD.
  • To evaluate the findings of ophthalmological screening in asymptomatic children with IBD.

Main Methods:

  • Systematic review of English literature published up to January 2018.
  • Searches conducted using PubMed and EMBASE databases with disease-specific queries.
  • Inclusion of fifteen studies reporting on O-EIMs prevalence in 7467 pediatric patients.

Main Results:

  • Overall O-EIM prevalence in children ranged from 0.62% to 1.82%, with uveitis being the most common.
  • Children with CD showed a significantly increased risk of O-EIMs compared to those with UC and IBD-U (OR 2.70).
  • Mild, asymptomatic uveitis was detected in 1.06-23.1% of screened asymptomatic children, particularly males with CD and colonic involvement.

Conclusions:

  • Data on pediatric O-EIMs are limited, and prevalence may be underestimated due to asymptomatic cases.
  • Children with CD appear to be at higher risk for O-EIMs.
  • While routine screening isn't recommended, a low threshold for ophthalmological referral is advised for pediatric IBD patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.1K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
652
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
743
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
860
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
688